RxDoctor Payments Data

Kulumani Sivarajan

Hematology & Oncology · Joliet, ILNPI 1952396582

Payments from drug & device makers

$19,430in general payments, 2019–2025

Across 101 payments — averaging $192.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$9K
  • GSK$2K
  • Beigene, Ltd.$2K
  • Bristol Myers Squibb$2K
  • Karyopharm Therapeutics Inc.$2K
  • Astrazeneca UK Limited$1K
  • plus $2K from 35 others

What the payments were for

  • Consulting fees$17,50390%
  • Speaking & faculty fees$2501%
  • Food & beverage$1,6248%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,430 in reported general payments places this provider in the 55th percentile of 580 hematology & oncology providers in Illinois.

See all hematology & oncology providers in Illinois

Other hematology & oncology in Joliet

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →